Fundraising Fox
/Companies
Sign in

Aragon Pharmaceuticals

San Diego, US · Founded 2009 · 3 known investors

Find your way into Aragon Pharmaceuticals

Sign up to see every warm intro you have to Aragon Pharmaceuticals

  • Paths you didn't know you had: your email and LinkedIn already hold routes to the Aragon Pharmaceuticals team. We find them for you
  • 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
  • Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone

Days of research, done the moment you sign in, with every route ranked by how warm it is.

Sign up with GoogleAlready have an account? Log in

Developing nuclear receptor-targeting drugs for hormone-resistant cancers; acquired by Johnson & Johnson in August 2013 for up to $1B.

Biotech

Founders & leadership

Aragon Pharmaceuticals was founded in 2009 by Richard A. Heyman.

RARichard A. Heyman
Richard A. HeymanFounder · President and CEO2009–2013Venture Partner at ARCH Venture Partners
AY
Angie YouExecutive
IC
Isan ChenExecutive

Board

CG
Carl GordonBoard director
PS
Peter SvennilsonBoard director
CG
Carol GallagherBoard director
LG
Leo GuthartBoard director
BZ
Brett ZbarBoard director

Investors · 3

Aisling CapitalreportedNew York

How we know: a partner's Signal profile · funding news · Not right? Tell us

OrbiMedreportedNew York · $1M – $75M

How we know: funding news · Not right? Tell us

Reported raises · per SEC filings

Form D private placements

$37.7M disclosed across 1 round · 2012

▶$37.7MraisedMar 2012 · 7 investors · Pharmaceuticals
Rule 506(b)
Officers, directors & promoters on the filing
  • Carl GordonDirector
  • Peter SvennilsonDirector
  • Carol GallagherDirector
  • Leo GuthartDirector
  • Richard A. HeymanExecutive Officer, Director
  • Angie YouExecutive Officer
  • Brett ZbarDirector
  • Isan ChenExecutive Officer
Offering amount
$42M
Amount sold
$37.7M
First sale
Feb 2012
Incorporated
Corporation, Delaware, 2009
Federal exemptions
06
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Frequently asked questions

What does Aragon Pharmaceuticals do?
Developing nuclear receptor-targeting drugs for hormone-resistant cancers; acquired by Johnson & Johnson in August 2013 for up to $1B.
Who founded Aragon Pharmaceuticals?
Aragon Pharmaceuticals was founded by Richard A. Heyman in 2009.
Who are Aragon Pharmaceuticals's investors?
Aragon Pharmaceuticals's investors include The Column Group, Aisling Capital, OrbiMed.
How much funding has Aragon Pharmaceuticals raised?
Aragon Pharmaceuticals has disclosed $37.7M raised across 1 round.
Where is Aragon Pharmaceuticals headquartered?
Aragon Pharmaceuticals is headquartered in San Diego, US.